Low-protein and protein-redistribution diets for Parkinson's disease patients with motor fluctuations: A systematic review

Movement Disorders

Volumn 25, Issue 13, 2010, Pages 2021-2034

  Cereda, Emanuele ^a   Barichella, Michela ^a   Pedrolli, Carlo ^b   Pezzoli, Gianni ^a  

^a PARKINSON INSTITUTE   (Italy)

^b Trento Hospital   (Italy)

Author keywords

Levodopa; Low Protein diet; Motor fluctuations; Parkinson's disease; Protein Redistribution diet

Indexed keywords

LEVODOPA;

EATING HABIT; HUMAN; MOTOR PERFORMANCE; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PARKINSON DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN DIET; PROTEIN INTAKE; PROTEIN RESTRICTION; REVIEW; TREATMENT RESPONSE;

ANIMALS; DIETARY PROTEINS; DOPAMINE AGENTS; HUMANS; LEVODOPA; MOTOR ACTIVITY; OUTCOME ASSESSMENT (HEALTH CARE); PARKINSON DISEASE; PROTEINS; PUBMED; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 78649381953     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23226     Document Type: Review

References (43)

1. Fahn S. The history of dopamine and levodopa in the treatment of Parkinson's disease. Mov Disord 2008;23 (Suppl 3):S497- S508.
2. Gillespie NG, Mena I, Cotzias GC, Bell MA. Diets affecting treatment of parkinsonism with levodopa. J Am Diet Assoc 1973;62:525-528.
3. Mena I, Cotzias GC. Protein intake and treatment of Parkinson's disease with levodopa. N Engl J Med 1975;292:181-184.
4. Grace AA. Physiology of the normal and dopamine-depleted basal ganglia: insights into levodopa pharmacotherapy. Mov Disord 2008;23 (Suppl 3):S560-S569.
5. Olanow CW, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines. American Academy of Neurology. Neurology 1998;50(3 Suppl 3):S1-S57.
6. Olanow CW, Watts RL, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines. Neurology 2001;56(11 Suppl 5):S1-S88.
7. Barichella M, Cereda E, Pezzoli G. Major nutritional issues in the management of Parkinson's disease. Mov Disord 2009;24(13): 1881-1892.
8. Nutt JG, Woodward WR, Hammerstad JP, Carter JH, Anderson JL. The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. N Engl J Med 1984;310:483-438.
9. Bozek CB, Suchowersky O, Purves S, Calne S, Calne DB. Sinemet in Parkinson's disease: efficacy with and without food. Clin Neuropharmacol 1986;9:196-199.
10. Baruzzi A, Contin M, Riva R, et al. Influence of meal ingestion time on pharmacokinetics of orally administered levodopa in parkinsonian patients. Clin Neuropharmacol 1987;10:527-537.
11. Juncos JL, Fabbrini G, Mouradian MM, Serrati C, Chase TN. Dietary influences on the antiparkinsonian response to LevoDOPA. Arch Neurol 1987;44:1003-1005.
12. Kurlan R. Dietary therapy for motor fluctuations in Parkinson's disease. Arch Neurol 1987;44:1119-1121.
13. Eriksson T, Granérus AK, Linde A, Carlsson A. 'On-off' phenomenon in Parkinson's disease: relationship between dopa and other large neutral amino acids in plasma. Neurology 1988;38: 1245-1248.
14. Karstaedt PJ, Pincus JH, Coughlin SS. Standard and controlled release levodopa/carbidopa in patients with fluctuating Parkinson's disease on a protein redistribution diet. A preliminary report. Arch Neurol 1991;48:402-405.
15. Berry EM, Growdon JH, Wurtman JJ, Caballero B, Wurtman RJ. A balanced carbohydrate: protein diet in the management of Parkinson's disease. Neurology 1991;41:1295-1297.
16. Sanchís G, Mena MA, Martín del Río R, Morales B, Casarejo MJ, de Yébenes MJ, Tabernero C, Jiménez A, de Yébenes JG. Effect of a controlled low-protein diet on the pharmacological response to levodopa and on the plasma levels of L-dopa and amino acids in patients with Parkinson's disease. Arch Neurobiol (Madr) 1991;54:296-302.
17. Giménez-Roldán S, Mateo D, García Almansa A, García Peris P. Proposal for a protein redistribution diet in the control of motor fluctuations in Parkinson's disease: acceptance and efficacy. Neurologia 1991;6:3-9.
18. Duarte J, Moreno C, Coria F, Pérez A, Clavería LE. Efficacy of the proteic redistribution diet (PRD) in the antiparkinsonian effect of L-dopa. Neurologia 1993;8:248-251.
19. Simon N, Gantcheva R, Bruguerolle B, Viallet F. The effects of a normal protein diet on levodopa plasma kinetics in advanced Parkinson's disease. Parkinsonism Relat Disord 2004;10:137- 142.
20. Pincus JH, Barry K. Influence of dietary protein on motor fluctuations in Parkinson's disease. Arch Neurol 1987;44:270-272.
21. Pincus JH, Barry KM. Dietary method for reducing fluctuations in Parkinson's disease. Yale J Biol Med 1987;60:133-137.
22. Pincus JH, Barry KM. Plasma levels of amino acids correlate with motor fluctuations in parkinsonism. Arch Neurol 1987;44:1006-1009.
23. Pincus JH, Barry K. Protein redistribution diet restores motor function in patients with dopa-resistant "off" periods. Neurology 1988;38:481-483.
24. Riley D, Lang AE. Practical application of a low protein diet for Parkinson's disease. Neurology 1988;38:1026-1031.
25. Tsui JK, Ross S, Poulin K, et al. The effect of dietary protein on the efficacy of L-dopa: a double-blind study. Neurology 1989;39: 549-552.
26. Carter JH, Nutt JG, Woodward WR, Hatcher LF, Trotman TL. Amount and distribution of dietary protein affects clinical response to levodopa in Parkinson's disease. Neurology 1989;39: 552-556.
27. Giménez-Roldán S, Mateo D. Predicting beneficial response to a protein-redistribution diet in fluctuating Parkinson's disease. Acta Neurol Belg 1991;91:189-200.
28. Croxson S, Johnson B, Millac P, Pye I. Dietary modification of Parkinson's disease. Eur J Clin Nutr 1991;45:263-266.
29. Bracco F, Malesani R, Saladini M, Battistin L. Protein redistribution diet and antiparkinsonian response to Levodopa. Eur Neurol 1991;31:68-71.
30. Karstaedt PJ, Pincus JM. Protein redistribution diet remains effective in patients with fluctuating parkinsonism. Arch Neurol 1992;49:149-151.
31. Paré S, Barr SI, Ross SE. Effect of daytime protein restriction on nutrient intakes of free-living Parkinson's Disease patients. Am J Clin Nutr 1992;55:701-707.
32. Barichella M, Marczewska A, De Notaris R, et al. Special lowprotein foods ameliorate postprandial off in patients with advanced Parkinson's disease. Mov Disord 2006;21:1682-1687.
33. Barichella M, Savardi C, Mauri A, et al. Diet with LPP for renal patients increases daily energy expenditure and improves motor function in parkinsonian patients with motor fluctuations. Nutr Neurosci 2007;10:129-135.
34. Wolfe RR, Miller SL, Miller KB. Optimal protein intake in the elderly. Clin Nutr 2008;27:675-84.
35. Contin M, Riva R, Albani F, Baruzzi A. Pharmacokinetic optimisation in the treatment of Parkinson's disease. Clin Pharmacokinet 1996;30:463-481.
36. Nyholm D. Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update. Clin Pharmacokinet 2006;45:109-136.
37. Marczewska A, De Notaris R, Sieri S, Barichella M, Fusconi E, Pezzoli G. Protein intake in Parkinsonian patients using the EPIC food frequency questionnaire. Mov Disord 2006;21:1229-1231.
38. Astarloa R, Mena MA, Sánchez V, de la Vega L, de Yébenes JG. Clinical and pharmacokinetic effects of a diet rich in insolu-ble fiber on Parkinson disease. Clin Neuropharmacol 1992;15: 375-380.
39. Hattoria N, Wanga M, Taka H, et al. Toxic effects of dopamine metabolism in Parkinson's disease. Parkinsonism Relat Disord 2009;15 (Suppl 1):S35-S38.
40. Norman K, Pichard C, Lochs H, Pirlich M. Prognostic impact of disease-related malnutrition. Clin Nutr 2008;27:5-15.
41. Abbott RA, Cox M, Markus H, Tomkins A. Diet, body size and micronutrient status in Parkinson's disease. Eur J Clin Nutr 1992;46:879-884.
42. Boyd AE, III, Lebovitz HE, Pfeiffer JB. Stimulation of human growth-hormone secretion by L-dopa. N Engl J Med 1970;283: 1425-1429.
43. Giovannini S, Marzetti E, Borst SE, Leeuwenburgh C. Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults. Mech Ageing Dev 2008;129:593-601.